BNP Paribas Financial Markets’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170 | Hold |
107
| – | – | ﹤0.01% | 4480 |
|
|
2025
Q1 | $159 | Sell |
107
-14
| -12% | -$21 | ﹤0.01% | 4392 |
|
|
2024
Q4 | $484 | Buy |
121
+2
| +2% | +$8 | ﹤0.01% | 4324 |
|
|
2024
Q3 | $1.49K | Hold |
119
| – | – | ﹤0.01% | 3185 |
|
|
2024
Q2 | $1.74K | Sell |
119
-2,666
| -96% | -$39K | ﹤0.01% | 3142 |
|
|
2024
Q1 | $62.5K | Buy |
2,785
+1,308
| +89% | +$29.3K | ﹤0.01% | 2875 |
|
|
2023
Q4 | $27.9K | Buy |
1,477
+552
| +60% | +$10.4K | ﹤0.01% | 2922 |
|
|
2023
Q3 | $15.8K | Sell |
925
-409
| -31% | -$7K | ﹤0.01% | 2904 |
|
|
2023
Q2 | $40K | Buy |
1,334
+1,282
| +2,465% | +$38.5K | ﹤0.01% | 2901 |
|
|
2023
Q1 | $1.51K | Sell |
52
-408
| -89% | -$11.9K | ﹤0.01% | 3023 |
|
|
2022
Q4 | $9.09K | Sell |
460
-2
| -0.4% | -$40 | ﹤0.01% | 2960 |
|
|
2022
Q3 | $14K | Sell |
462
-423
| -48% | -$12.8K | ﹤0.01% | 3427 |
|
|
2022
Q2 | $20.4K | Buy |
885
+331
| +60% | +$7.62K | ﹤0.01% | 3053 |
|
|
2022
Q1 | $24.8K | Sell |
554
-1,223
| -69% | -$54.8K | ﹤0.01% | 3123 |
|
|
2021
Q4 | $68.4K | Buy |
1,777
+685
| +63% | +$26.4K | ﹤0.01% | 3045 |
|
|
2021
Q3 | $55.4K | Buy |
1,092
+612
| +128% | +$31.1K | ﹤0.01% | 2895 |
|
|
2021
Q2 | $41.8K | Buy |
+480
| New | +$41.8K | ﹤0.01% | 2731 |
|